Credit Suisse’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,744,843
| Closed | -$321M | – | 4679 |
|
|
2021
Q2 | $321M | Buy |
1,744,843
+373,222
| +27% | +$64.1M | 0.25% | 98 |
|
|
2021
Q1 | $210M | Sell |
1,371,621
-378,840
| -22% | -$58.6M | 0.16% | 198 |
|
|
2020
Q4 | $273M | Sell |
1,750,461
-211,695
| -11% | -$27.2M | 0.2% | 141 |
|
|
2020
Q3 | $225M | Sell |
1,962,156
-148,259
| -7% | -$16M | 0.2% | 141 |
|
|
2020
Q2 | $237M | Sell |
2,110,415
-1,064,144
| -34% | -$113M | 0.22% | 108 |
|
|
2020
Q1 | $285M | Buy |
3,174,559
+416,206
| +15% | +$40.8M | 0.32% | 70 |
|
|
2019
Q4 | $298M | Buy |
2,758,353
+763,163
| +38% | +$81.6M | 0.29% | 73 |
|
|
2019
Q3 | $195M | Buy |
1,995,190
+1,632,827
| +451% | +$184M | 0.23% | 107 |
|
|
2019
Q2 | $47.5M | Sell |
362,363
-14,180
| -4% | -$1.83M | 0.06% | 464 |
|
|
2019
Q1 | $50.9M | Buy |
376,543
+22,666
| +6% | +$2.82M | 0.07% | 417 |
|
|
2018
Q4 | $34.5M | Sell |
353,877
-4,778
| -1% | -$565K | 0.05% | 521 |
|
|
2018
Q3 | $49.9M | Buy |
358,655
+77,003
| +27% | +$9.66M | 0.06% | 424 |
|
|
2018
Q2 | $35M | Sell |
281,652
-44,809
| -14% | -$5.24M | 0.05% | 540 |
|
|
2018
Q1 | $36.4M | Sell |
326,461
-62,508
| -16% | -$7.47M | 0.04% | 563 |
|
|
2017
Q4 | $46.5M | Sell |
388,969
-30,170
| -7% | -$3.67M | 0.05% | 451 |
|
|
2017
Q3 | $58.8M | Sell |
419,139
-89,599
| -18% | -$12.2M | 0.07% | 368 |
|
|
2017
Q2 | $61.9M | Sell |
508,738
-60,228
| -11% | -$7.01M | 0.08% | 326 |
|
|
2017
Q1 | $69M | Buy |
568,966
+86,141
| +18% | +$11.1M | 0.08% | 325 |
|
|
2016
Q4 | $59.1M | Sell |
482,825
-113,742
| -19% | -$13.9M | 0.07% | 344 |
|
|
2016
Q3 | $73.1M | Buy |
596,567
+17,715
| +3% | +$2.28M | 0.08% | 287 |
|
|
2016
Q2 | $67.6M | Buy |
578,852
+37,492
| +7% | +$5.32M | 0.09% | 256 |
|
|
2016
Q1 | $75.4M | Buy |
541,360
+18,558
| +4% | +$2.72M | 0.1% | 227 |
|
|
2015
Q4 | $99.7M | Buy |
522,802
+34,833
| +7% | +$6.08M | 0.12% | 179 |
|
|
2015
Q3 | $76.3M | Sell |
487,969
-147,862
| -23% | -$27M | 0.1% | 230 |
|
|
2015
Q2 | $115M | Buy |
635,831
+87,081
| +16% | +$15M | 0.12% | 189 |
|
|
2015
Q1 | $95.1M | Sell |
548,750
-29,610
| -5% | -$5.36M | 0.11% | 220 |
|
|
2014
Q4 | $107M | Buy |
578,360
+33,640
| +6% | +$6.23M | 0.11% | 207 |
|
|
2014
Q3 | $90.3M | Buy |
544,720
+76,687
| +16% | +$12.6M | 0.09% | 265 |
|
|
2014
Q2 | $73.1M | Sell |
468,033
-22,786
| -5% | -$3.6M | 0.07% | 337 |
|
|
2014
Q1 | $74.7M | Sell |
490,819
-73,999
| -13% | -$11.8M | 0.09% | 271 |
|
|
2013
Q4 | $75.1M | Buy |
564,818
+97,377
| +21% | +$11.7M | 0.09% | 274 |
|
|
2013
Q3 | $54.3M | Sell |
467,441
-125,846
| -21% | -$13.8M | 0.07% | 325 |
|
|
2013
Q2 | $54.7M | Buy |
+593,287
| New | +$57.2M | 0.07% | 344 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM